| ∧ ∨ Type | ∧ ∨ Title | Principal Investigators | Status | ∧ ∨ Year |
|---|---|---|---|---|
| PRIN2017 - PRIN bando 2017 |
Early life stress and psychopathology: unraveling the mechanisms of vulnerability and resilience
|
|
Closed | 2019 |
| PRIN2017 - PRIN bando 2017 |
Multi-center Translational Trial of Remote Ischemic Conditioning in Acute Ischemic Stroke (TRICS). A collaborative study from the Italian Stroke Organization (ISO) Basic Science network
|
|
Closed | 2019 |
| PRIN2017 - PRIN bando 2017 |
The interplay between the “rna/protein quality control system” and “exosomes” as a spreading mechanism in amyotrophic lateral sclerosis (EX_ALS)
|
|
Closed | 2019 |
| PRIN2017 - PRIN bando 2017 |
Identification and validation of COmmon pathways at the CrOssrOads of neurodegeneration and Neuroprotection (COCOON)
|
|
Closed | 2019 |
| PRIN2017 - PRIN bando 2017 |
Early life social experiences and dysregulation of the brain reward system: The role of endocannabinoid transmission
|
|
Closed | 2019 |
| PRIN2017 - PRIN bando 2017 |
tArGeting brAIn cholesterol traNSporT in Alzheimer’s Disease (AGAINST-AD)
|
|
Closed | 2019 |
| PRIN2017 - PRIN bando 2017 |
Low density lipoprotein receptor (LDLR)-independent effects of proprotein convertase subtilisin/kexin type 9 (PCSK9): role in modulating insulin-resistance, ectopic fat accumulation and low-grade inflammation
|
|
Closed | 2019 |
| PRIN2017 - PRIN bando 2017 |
Pathogenesis of Chemotherapy-Induced Peripheral Neurotoxicity (Pa-CIPN)
|
|
Closed | 2019 |
| PRIN2017 - PRIN bando 2017 |
Role of alpha-synuclein and LRRK2 in Levodopa-induced dyskinesia
|
|
Closed | 2019 |
| PRIN2017 - PRIN bando 2017 |
Drug repurposing as a novel strategy to discover pro-regenerative therapies for neurological diseases: the challenge of progressive multiple sclerosis
|
|
Closed | 2019 |
